UPDATE: Phibro Animal Health (PAHC) Tops Q2 EPS by 6c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Phibro Animal Health Corporation Reports Second Quarter Results
February 3, 2020 4:40 PM ESTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its second quarter ended December 31, 2019.
Highlights for the December 2019 quarter (compared to the December 2018 quarter)
Net sales of $214 million, a decrease of $4 million, or 2% Net income of $12 million, a decrease of $3 million, or 19% Diluted EPS of $0.29, a decrease of $0.07, or 19% Adjusted EBITDA of $29 million, a decrease of $3 million, or... More


